In focus
Latest feed
A New Chapter for Psoriatic Arthritis: Bristol Myers Squibb's Sotyktu Wins Key FDA Approval
Bristol Myers Squibb Announces Significant Operational Shift in Devens, Leading to Job Losses
Bristol Myers Squibb: Navigating the Patent Storm, Still a Cash Machine?
Bristol Myers Squibb: A Cautious Optimism Amidst Looming Headwinds
